"I believe we have a unique opportunity to initiate a new position in a company that is still under the radar of most investors: CoreSite Realty Corp. (COR)," says growth and income specialist Bryan Perry.

The editor of The Cash Machine explains, "CoreSite is structured as a REIT intended to meet the strict needs of the information technology community; it manages more than 2 million square feet of data center space for more than 600 customers.

"Since the company's founding in 2001, CEO Thomas Ray has been in charge of the company's actions. (Before the initial public offering in September, Ray also served as a managing director of The Carlyle Group.)

Continue reading CoreSite (COR): Total Return from Data Center REIT

CoreSite (COR): Total Return from Data Center REIT originally appeared on BloggingStocks on Thu, 09 Dec 2010 12:45:00 EST. Please see our terms for use of feeds.

Analyst Upgrades

• State Street (STT) was upgraded to buy from neutral at Goldman.
• Roth Capital upgraded Intel (INTC), Marvell Technology (MRVL) and Nvidia (NVDA) to buy from neutral.
• Bebe Stores (BEBE) was upgraded to buy from neutral at Janney Montgomery.
• W&T Offshore (WTI) was upgraded to buy from accumulate at Global Hunter.
• Citigroup upgraded International Rectifier (IRF) and Timberland (TBL) to hold from sell.
• Watson Pharma (WPI) was upgraded to buy from neutral at UBS.
• Atmel (ATML) was upgraded to strong buy from buy at Needham.
• Ashford Hospitality (AHT) was upgraded to outperform from neutral at RW Baird.
• Oppenheimer upgraded MetroPCS (PCS) to outperform from perform.

Continue reading Analyst Calls: GDP, INTC, LVS, MON, MRVL, NTRS, NVDA, STT, WYNN ...

Analyst Calls: GDP, INTC, LVS, MON, MRVL, NTRS, NVDA, STT, WYNN ... originally appeared on BloggingStocks on Fri, 05 Nov 2010 11:30:00 EST. Please see our terms for use of feeds.

MOST NOTEWORTHY:

• Rodman & Renshaw upgraded Cortex Pharma (AMEX:COR) to Market Perform from Underperform citing the company's progress towards renewing its pipeline and notes that results from two proof-of-concept studies assessing acute administration of COR's lead AMPAKINE molecule are expected in the coming months.
  
• Citigroup upgraded shares of Royal Bank of Scotland (NYSE:RBS) to Buy from Hold on valuation following the recent weakness, as they believe the sell-off has been excessive.
  
• Suntrust raised Trex (NYSE:TWP) to Buy from Neutral based on management's turnaround efforts, expectations for increased market share in composite decking, and valuation, among other reasons.

• Friedman Billings upgraded Hot Topic (NASDAQ:HOTT) to Outperform from Market Perform.
  
• Lehman raised UAL Corp (NASDAQ:UAUA) and Northwest Airlines (NWA) to Overweight from Equal Weight.
  
• Goldman added Eli Lilly (NYSE:LLY) to its Conviction Buy List.

Analyst upgrades: COR, RBS and TWP originally appeared on BloggingStocks on Thu, 05 Jun 2008 11:12:00 EST. Please see our terms for use of feeds.